A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection

Craniopharyngioma Craniopharyngioma

Craniopharyngioma With Tumoral Hemorrhage Neuromodulation for Hypothalamic Obesity An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions Intranasal Oxytocin in Hypothalamic Obesity Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy Weight Gain in Surgically Treated Adult-onset Craniopharyngioma Sleep Wake and Melatonin Pattern in Craniopharyngioma 1.5T Intraoperative MR Imaging in Craniopharyngiomas Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection Prospective Study of Children and Adolescents With Craniopharyngioma Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)